STOCK TITAN
The best stock market news and trading tools all in one place—your must-have platform for investing success.
A must-have platform for stock market information, offering the best tools and updates to supercharge your trading.
Your trusted source for the best stock market news, trading tools, and expert advice. Everything traders need, in one place.

Eagle Pharmaceuticals to Present at the 2021 RBC Capital Markets Global Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) will present at the 2021 RBC Capital Markets Global Healthcare Conference on May 18, 2021, at 1:20 p.m. Eastern Time. CEO Scott Tarriff and CFO Brian Cahill will lead the presentation, which will be available via a live webcast and archived for 30 days on the company’s website under the Investors Section. Eagle is dedicated to developing innovative medicines, with commercialized products including RYANODEX®, BENDEKA®, and BELRAPZO®. For more information, visit www.eagleus.com.

Positive
  • None.
Negative
  • None.

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 2021 RBC Capital Markets Global Healthcare Conference as follows:

Date:

Tuesday, May 18, 2021

Time:

1:20 p.m. Eastern Time

Webcast:

https://event.on24.com/wcc/r/3173733/CEA9B803E5C77274A4417D4FE2A0EAB0

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include RYANODEX®, BENDEKA®, BELRAPZO®, and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

FAQ

When is Eagle Pharmaceuticals' presentation at the RBC Capital Markets Global Healthcare Conference?

Eagle Pharmaceuticals will present on May 18, 2021, at 1:20 p.m. Eastern Time.

Who will represent Eagle Pharmaceuticals at the RBC Capital Markets Global Healthcare Conference?

Scott Tarriff, CEO, and Brian Cahill, CFO, will represent Eagle Pharmaceuticals.

How can I watch Eagle Pharmaceuticals' presentation from the RBC Capital Markets Global Healthcare Conference?

The presentation will be available via a live webcast and can be accessed on the company's website.

What products does Eagle Pharmaceuticals currently market?

Eagle Pharmaceuticals markets RYANODEX®, BENDEKA®, and BELRAPZO®.

Is there a recording of the Eagle Pharmaceuticals presentation available?

Yes, the presentation will be archived for 30 days on Eagle's website.

Where can I find more information about Eagle Pharmaceuticals?

More information is available on Eagle Pharmaceuticals' website at www.eagleus.com.

EAGLE PHARMS INC

OTC:EGRX

EGRX Rankings

EGRX Latest News

EGRX Stock Data

26.56M
11.43M
12.02%
80.9%
2.71%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
WOODCLIFF LAKE